Tadamitsu Kishimoto Selected Research

Tadamitsu Kishimoto Research Topics

Disease

30	Rheumatoid Arthritis 05/2022 - 01/2002
27	Inflammation (Inflammations) 11/2022 - 01/2002
19	Neoplasms (Cancer) 11/2022 - 02/2002
19	Juvenile Arthritis (Juvenile Idiopathic Arthritis) 01/2022 - 08/2004
18	Infections 11/2022 - 11/2002
17	Castleman Disease (Castleman's Disease) 05/2022 - 01/2002
15	Arthritis (Polyarthritis) 01/2021 - 06/2002
13	Autoimmune Diseases (Autoimmune Disease) 01/2020 - 02/2004
10	Cytokine Release Syndrome 01/2022 - 01/2015
8	Wounds and Injuries (Trauma) 01/2021 - 02/2014
6	Colitis 11/2018 - 11/2002
5	COVID-19 01/2022 - 01/2020
5	Sepsis (Septicemia) 01/2021 - 01/2016
5	Crohn Disease (Crohn's Disease) 02/2011 - 11/2002
4	Takayasu Arteritis (Arteritis, Takayasu's) 01/2020 - 01/2013
4	Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental) 01/2019 - 07/2008
4	Systemic Inflammatory Response Syndrome (Sepsis Syndrome) 01/2018 - 01/2015
4	Systemic Juvenile Rheumatoid Arthritis 04/2014 - 11/2006
3	Systemic Scleroderma (Systemic Sclerosis) 05/2022 - 12/2010
3	Giant Cell Arteritis (Horton Disease) 01/2020 - 11/2018
3	Septic Shock (Toxic Shock Syndrome) 01/2019 - 10/2016
3	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 11/2018 - 01/2009
3	Shock 01/2018 - 11/2002
3	Multiple Myeloma 01/2017 - 01/2002
3	Acute-Phase Reaction 01/2016 - 02/2014
3	Experimental Arthritis 08/2011 - 01/2003
3	Anemia 01/2011 - 12/2002
2	Immune System Diseases (Immune Disorders) 11/2022 - 05/2022
2	Pulmonary Hypertension 01/2021 - 05/2015
2	Hypoxia (Hypoxemia) 01/2021 - 05/2015
2	Pulmonary Arterial Hypertension 01/2021 - 05/2015
2	Reactive Arthritis (Reiter Disease) 01/2019 - 12/2009
2	Polymyalgia Rheumatica (Rhizomelic Pseudopolyarthritis) 01/2019 - 05/2010
2	Hematologic Neoplasms (Hematological Malignancy) 11/2018 - 05/2002
2	Multiple Sclerosis 07/2013 - 07/2010
2	Malignant Mesothelioma 01/2013 - 08/2011
2	Fever (Fevers) 01/2011 - 09/2010
2	Anorexia 01/2011 - 05/2008
2	Fatigue 01/2011 - 05/2008
2	Carcinogenesis 05/2010 - 01/2002
2	Asthma (Bronchial Asthma) 06/2007 - 02/2005
2	Reperfusion Injury 05/2007 - 02/2005
2	Glomerulonephritis 02/2004 - 12/2002
1	Interstitial Lung Diseases (Interstitial Lung Disease) 05/2022
1	Neuromyelitis Optica (Devic's Disease) 05/2022
1	Communicable Diseases (Infectious Diseases) 05/2022
1	Breast Neoplasms (Breast Cancer) 11/2021
1	Neoplasm Metastasis (Metastasis) 11/2021
1	Burns 01/2020
1	Bacterial Infections (Bacterial Infection) 01/2020
1	Rheumatic Diseases (Rheumatism) 01/2020
1	Respiratory Distress Syndrome (Acute Respiratory Distress Syndrome) 01/2020
1	Adult-Onset Still's Disease 01/2020

Drug/Important Bio-Agent (IBA)

58	Interleukin-6 (Interleukin 6)IBA 11/2022 - 01/2002
38	tocilizumab (atlizumab)FDA Link 01/2022 - 03/2005
33	CytokinesIBA 11/2022 - 01/2002
12	Monoclonal AntibodiesIBA 01/2020 - 11/2002
12	Interleukin-6 Receptors (Interleukin 6 Receptor)IBA 01/2019 - 07/2003
8	Aryl Hydrocarbon Receptors (Aryl Hydrocarbon Receptor)IBA 01/2021 - 08/2011
7	Proteins (Proteins, Gene)FDA Link 01/2021 - 01/2003
7	Biological ProductsIBA 01/2019 - 01/2002
6	RNA-Binding Proteins (RNA-Binding Protein)IBA 11/2022 - 01/2017
6	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 11/2022 - 06/2002
6	Messenger RNA (mRNA)IBA 01/2020 - 04/2004
5	InterleukinsIBA 11/2021 - 04/2005
5	Therapeutic UsesIBA 01/2019 - 01/2009
5	Immunoglobulin G (IgG)IBA 02/2012 - 05/2002
4	AutoantibodiesIBA 05/2022 - 02/2004
4	Acute-Phase Proteins (Acute-Phase Protein)IBA 01/2022 - 03/2005
4	Chimeric Antigen ReceptorsIBA 01/2022 - 01/2020
4	Pharmaceutical PreparationsIBA 01/2021 - 05/2008
4	Interleukin-17 (Interleukin 17)IBA 05/2015 - 03/2008
3	Immunomodulating AgentsIBA 11/2018 - 01/2016
3	LipopolysaccharidesIBA 01/2018 - 03/2014
3	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2011 - 06/2003
3	AntigensIBA 04/2010 - 06/2002
2	carbazoleIBA 01/2021 - 06/2013
2	Thalidomide (Thalomid)FDA Link 11/2018 - 01/2016
2	Dextrans (Dextran)FDA Link 11/2018 - 08/2015
2	sodium sulfate (sodium bisulfate)FDA LinkGeneric 11/2018 - 08/2015
2	LigandsIBA 01/2018 - 01/2011
2	MicroRNAs (MicroRNA)IBA 08/2015 - 01/2014
2	Biomarkers (Surrogate Marker)IBA 02/2012 - 04/2010
2	Adrenal Cortex Hormones (Corticosteroids)IBA 08/2011 - 03/2005
2	Tumor Necrosis Factor Receptors (Tumor Necrosis Factor Receptor)IBA 02/2011 - 01/2003
2	C-Reactive ProteinIBA 01/2011 - 09/2010
2	AntibodiesIBA 06/2007 - 05/2002
2	Immunoglobulin M (IgM)IBA 01/2005 - 05/2002
1	Indomethacin (Indometacin)FDA LinkGeneric 04/2022
1	Long Noncoding RNAIBA 11/2021
1	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 11/2021
1	Semaxinib (SU5416)IBA 01/2021
1	Vascular Endothelial Growth Factor Receptor-2 (Vascular Endothelial Growth Factor Receptor 2)IBA 01/2021
1	Qingdai compoundIBA 01/2021
1	Environmental BiomarkersIBA 01/2021
1	Interleukin-8 (Interleukin 8)IBA 01/2020
1	Plasminogen Activator Inhibitor 1IBA 01/2020

Therapy/Procedure

22	Therapeutics 05/2022 - 12/2002
3	Off-Label Use 01/2015 - 02/2014
2	Immunotherapy 11/2022 - 05/2002